These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18427112)

  • 1. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria.
    Gefen O; Gabay C; Mumcuoglu M; Engel G; Balaban NQ
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6145-9. PubMed ID: 18427112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
    Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
    mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dormancy is not necessary or sufficient for bacterial persistence.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3230-9. PubMed ID: 23629720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response.
    Wood WN; Mohler K; Rinehart J; Ibba M
    mBio; 2021 Jun; 12(3):e0113221. PubMed ID: 34126764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
    Morgan J; Smith M; Mc Auley MT; Enrique Salcedo-Sora J
    Microbiology (Reading); 2018 Nov; 164(11):1432-1445. PubMed ID: 30247120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active efflux in dormant bacterial cells - New insights into antibiotic persistence.
    Pu Y; Ke Y; Bai F
    Drug Resist Updat; 2017 Jan; 30():7-14. PubMed ID: 28363336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas syringae pv.
    Patel RR; Kandel PP; Traverso E; Hockett KL; Triplett LR
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li Y; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-cytometry analysis reveals persister resuscitation characteristics.
    Mohiuddin SG; Kavousi P; Orman MA
    BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
    Jõers A; Kaldalu N; Tenson T
    J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum.
    Ayrapetyan M; Williams TC; Baxter R; Oliver JD
    Infect Immun; 2015 Nov; 83(11):4194-203. PubMed ID: 26283335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ploidy is an important determinant of fluoroquinolone persister survival.
    Murawski AM; Brynildsen MP
    Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial persistence as a phenotypic switch.
    Balaban NQ; Merrin J; Chait R; Kowalik L; Leibler S
    Science; 2004 Sep; 305(5690):1622-5. PubMed ID: 15308767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persister control by leveraging dormancy associated reduction of antibiotic efflux.
    Roy S; Bahar AA; Gu H; Nangia S; Sauer K; Ren D
    PLoS Pathog; 2021 Dec; 17(12):e1010144. PubMed ID: 34890435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.